IBDEI3J2 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,2606,0)
 ;;=PARAPHILIC DISORDERS^19^237
 ;;^UTILITY(U,$J,358.4,2607,0)
 ;;=PERSONALITY DISORDERS^21^237
 ;;^UTILITY(U,$J,358.4,2608,0)
 ;;=CRIME/LEGAL SYSTEM PROBLEMS^6^237
 ;;^UTILITY(U,$J,358.4,2609,0)
 ;;=PSYCHOSOCIAL/PERSONAL/ENVIRONMENTAL^22^237
 ;;^UTILITY(U,$J,358.4,2610,0)
 ;;=RELATIONAL PROBLEMS^23^237
 ;;^UTILITY(U,$J,358.4,2611,0)
 ;;=SCHIZOPHRENIA/OTH PSYCHOTIC DISORDERS^25^237
 ;;^UTILITY(U,$J,358.4,2612,0)
 ;;=SEXUAL DYSFUNCTION^26^237
 ;;^UTILITY(U,$J,358.4,2613,0)
 ;;=SLEEP DISORDERS^27^237
 ;;^UTILITY(U,$J,358.4,2614,0)
 ;;=SUBSTANCE ABUSE-ALCOHOL^30^237
 ;;^UTILITY(U,$J,358.4,2615,0)
 ;;=SUBSTANCE ABUSE-AMPHETAMINE^31^237
 ;;^UTILITY(U,$J,358.4,2616,0)
 ;;=SUBSTANCE ABUSE-CANNABIS^32^237
 ;;^UTILITY(U,$J,358.4,2617,0)
 ;;=SUBSTANCE ABUSE-HALLUCINOGEN^34^237
 ;;^UTILITY(U,$J,358.4,2618,0)
 ;;=SUBSTANCE ABUSE-OPIOID^36^237
 ;;^UTILITY(U,$J,358.4,2619,0)
 ;;=SUBSTANCE ABUSE-PSYCHOACTIVE DRUGS^37^237
 ;;^UTILITY(U,$J,358.4,2620,0)
 ;;=SUBSTANCE ABUSE-SEDATIVE/HYPNOTIC^38^237
 ;;^UTILITY(U,$J,358.4,2621,0)
 ;;=SUBSTANCE ABUSE-TOBACCO^39^237
 ;;^UTILITY(U,$J,358.4,2622,0)
 ;;=SUBSTANCE ABUSE-COCAINE^33^237
 ;;^UTILITY(U,$J,358.4,2623,0)
 ;;=TRAUMA/STRESSOR-RELATED DISORDERS^40^237
 ;;^UTILITY(U,$J,358.4,2624,0)
 ;;=SUBSTANCE ABUSE-INHALANT^35^237
 ;;^UTILITY(U,$J,358.4,2625,0)
 ;;=INTELLECTUAL DISABILITIES^15^237
 ;;^UTILITY(U,$J,358.4,2626,0)
 ;;=RESEARCH^24^237
 ;;^UTILITY(U,$J,358.4,2627,0)
 ;;=SOMATOFORM DISORDERS^29^237
 ;;^UTILITY(U,$J,358.4,2628,0)
 ;;=NEW PATIENT^2^238
 ;;^UTILITY(U,$J,358.4,2629,0)
 ;;=ESTABLISHED PATIENT^1^238
 ;;^UTILITY(U,$J,358.4,2630,0)
 ;;=CONSULTATIONS^3^238
 ;;^UTILITY(U,$J,358.4,2631,0)
 ;;=IMMUNIZATIONS^5^239
 ;;^UTILITY(U,$J,358.4,2632,0)
 ;;=COUNSELING^1^239
 ;;^UTILITY(U,$J,358.4,2633,0)
 ;;=EDUCATION^2^239
 ;;^UTILITY(U,$J,358.4,2634,0)
 ;;=EVALUATIONS^3^239
 ;;^UTILITY(U,$J,358.4,2635,0)
 ;;=IMMUNIZATION ADMINISTRATION^4^239
 ;;^UTILITY(U,$J,358.4,2636,0)
 ;;=TREATMENT PROCEDURES^7^239
 ;;^UTILITY(U,$J,358.4,2637,0)
 ;;=INJECTIONS^6^239
 ;;^UTILITY(U,$J,358.4,2638,0)
 ;;=TBI SCREENING^1^240
 ;;^UTILITY(U,$J,358.4,2639,0)
 ;;=MENTAL HEALTH^4^240
 ;;^UTILITY(U,$J,358.4,2640,0)
 ;;=NEUROLOGY^5^240
 ;;^UTILITY(U,$J,358.4,2641,0)
 ;;=HEADACHES^2^240
 ;;^UTILITY(U,$J,358.4,2642,0)
 ;;=HISTORY OF ILLNESS^3^240
 ;;^UTILITY(U,$J,358.4,2643,0)
 ;;=SIGNS, SYMPTOMS, CONDITIONS^6^240
 ;;^UTILITY(U,$J,358.4,2644,0)
 ;;=CAUSES OF INJURY (SECONDARY DX ONLY)^7^240
 ;;^UTILITY(U,$J,358.4,2645,0)
 ;;=NEW PATIENT^2^241
 ;;^UTILITY(U,$J,358.4,2646,0)
 ;;=ESTABLISHED PATIENT^1^241
 ;;^UTILITY(U,$J,358.4,2647,0)
 ;;=CONSULTATIONS^3^241
 ;;^UTILITY(U,$J,358.4,2648,0)
 ;;=TELEHEALTH FACILITY FEE^1^242
 ;;^UTILITY(U,$J,358.4,2649,0)
 ;;=A DIAGNOSES^1^243
 ;;^UTILITY(U,$J,358.4,2650,0)
 ;;=D DIAGNOSES^4^243
 ;;^UTILITY(U,$J,358.4,2651,0)
 ;;=E DIAGNOSES^5^243
 ;;^UTILITY(U,$J,358.4,2652,0)
 ;;=F DIAGNOSES^6^243
 ;;^UTILITY(U,$J,358.4,2653,0)
 ;;=I DIAGNOSES^9^243
 ;;^UTILITY(U,$J,358.4,2654,0)
 ;;=K DIAGNOSES^10^243
 ;;^UTILITY(U,$J,358.4,2655,0)
 ;;=M DIAGNOSES^12^243
 ;;^UTILITY(U,$J,358.4,2656,0)
 ;;=N DIAGNOSES^13^243
 ;;^UTILITY(U,$J,358.4,2657,0)
 ;;=P DIAGNOSES^15^243
 ;;^UTILITY(U,$J,358.4,2658,0)
 ;;=R DIAGNOSES^16^243
 ;;^UTILITY(U,$J,358.4,2659,0)
 ;;=S DIAGNOSES^17^243
 ;;^UTILITY(U,$J,358.4,2660,0)
 ;;=T DIAGNOSES^18^243
 ;;^UTILITY(U,$J,358.4,2661,0)
 ;;=V DIAGNOSES^20^243
 ;;^UTILITY(U,$J,358.4,2662,0)
 ;;=X DIAGNOSES^22^243
 ;;^UTILITY(U,$J,358.4,2663,0)
 ;;=C DIAGNOSES^3^243
 ;;^UTILITY(U,$J,358.4,2664,0)
 ;;=W DIAGNOSES^21^243
